New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

AHPA seeks FDA commitment on overdue AER guidance

(October 4, 2007) — As the dietary supplements and over-the-counter medicines industries prepare to comply with a new law on serious adverse event reports (AERs), the American Herbal Products Association (AHPA) has requested a publication date for an overdue guidance document. That guidance was to have been published by September 18; the law itself goes into effect on December 22, 2007.

AHPA made its requests today in a formal letter to the Food and Drug Administration (FDA) and its parent agency, the U.S. Department of Health and Human Services (HHS). When it goes into effect the Dietary Supplement and Nonprescription Drug Consumer Protection Act will require that information on serious AERs associated with dietary supplements and OTC drugs be submitted to FDA. When a law is passed, the agencies tasked with enforcement issue guidance documents detailing how the law is to be put into effect. In the AER Act itself, the U.S. Congress required the Secretary of Health and Human Services to “issue guidance on the minimum data elements that should be included in a serious adverse event report as described under the amendments made by this Act.”

“Congress clearly intended that businesses would have at least 90 days to digest the FDA’s guidance and make any necessary changes to their staff or procedures in order be ready to comply with the law when it goes into effect,” said AHPA President Michael McGuffin. “As of today, we’ve less than 80 days, and the clock is ticking.”

AHPA also asked HHS and FDA whether, in the absence of clear guidance, FDA would exercise enforcement discretion if companies do not submit AERs as the agency wishes.

“There’s no question that the law goes into effect on December 22,” McGuffin said. “Companies are already preparing to submit any serious AERs they receive. However, it’s inefficient and confusing to establish a procedure that may change when guidance is finally produced.”

On August 13, AHPA wrote FDA about the pending guidance, making several suggestions and requests that would help industry comply with the new AER law. AHPA’s August letter is online at:

AHPA’s October 4 letter is also available on the association’s website at


The American Herbal Products Association (AHPA) is the only national trade association devoted to herbal issues. Representing the core of the botanical trade—comprised of the finest growers, processors, manufacturers and marketers of herbal products—our mission is to promote the responsible commerce of herbal products. AHPA committees generate self-regulations to ensure the highest level of quality with respect to the way herbal products are manufactured, labeled, and sold. Celebrating our 25th anniversary in 2007! Website:

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.